• Citer

A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome.

par Morris, Peter E;Papadakos, Peter;Russell, James;Wunderink, Richard;Schuster, Daniel P.;Truwit, Jonathon D;Vincent, Jean Louis ;Bernard, Gordon
Référence Critical care medicine, 36, 3, page (782-788)
Publication Publié, 2008-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome.
Auteur:	Morris, Peter E; Papadakos, Peter; Russell, James; Wunderink, Richard; Schuster, Daniel P.; Truwit, Jonathon D; Vincent, Jean Louis; Bernard, Gordon
Informations sur la publication:	Critical care medicine, 36, 3, page (782-788)
Statut de publication:	Publié, 2008-03
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Acute respiratory distress syndrome
	Glutathione
	Oxothiazolidine-4-carboxylic acid
MeSH keywords:	Adolescent
	Adult
	Aged
	Aged, 80 and over
	Double-Blind Method
	Female
	Humans
	Male
	Middle Aged
	Pyrrolidonecarboxylic Acid -- therapeutic use
	Respiratory Distress Syndrome, Adult -- drug therapy
	Thiazolidines -- therapeutic use
Note générale:	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0090-3493
	info:doi/10.1097/CCM.0B013E318164E7E4
	info:scp/44449111361
	info:pmid/18209670